Legal woes drive Rite Aid to consider bankruptcy and store closures amid opioid litigation

USA — Rite Aid, a prominent player in the pharmacy industry, finds itself at a crossroads, engaged in high-stakes negotiations with creditors.

The talks are centered around a potentially seismic bankruptcy plan that would involve the liquidation of a significant portion of its vast network of over 2,100 drugstores.

This unfolding drama, reported by the Wall Street Journal, could reshape the company’s future.

According to insiders familiar with the discussions, Rite Aid has proposed a daring plan to close approximately 400 to 500 stores during bankruptcy proceedings.

The remaining operations would either be sold off or handed over to creditors. The scale of this endeavor is indicative of the financial turmoil that has engulfed the company, which is grappling with a staggering debt load surpassing US$3.3 billion.

In response to these reports, Rite Aid has acknowledged the ongoing negotiations but emphasized that no final decisions have been reached at this juncture.

While Rite Aid maintains a presence in 17 U.S. states with more than 2,330 stores, it pales in comparison to industry giants like Walgreens Boots Alliance and CVS Health.

The prospect of bankruptcy is driven not only by its crippling debt but also by an avalanche of legal challenges, including over a thousand federal lawsuits alleging its involvement in the opioid epidemic.

These multibillion-dollar debts and the weight of legal actions targeting the company’s alleged oversupply of prescription painkillers are expected to be addressed through a Chapter 11 filing.

The U.S. Department of Justice has taken Rite Aid to court, accusing the company of knowingly dispensing “unlawful prescriptions for controlled substances” in violation of both the False Claims Act and the Controlled Substances Act.

In response to these allegations, Rite Aid fervently denies any wrongdoing. A bankruptcy filing, if pursued, could temporarily halt these lawsuits and provide the company with a potential avenue to resolve them, as suggested by the Wall Street Journal.

Furthermore, bankruptcy might offer Rite Aid a lifeline for dealing with a pressing issue: a number of its stores are ensnared in financially burdensome long-term leases.

A bankruptcy declaration could provide a pragmatic means to shed these uneconomical obligations.

In a bid to navigate these treacherous waters, Rite Aid is reportedly planning to conduct an auction to divest assets, including its Elxir pharmacy unit.

The outcome of these strategic moves will significantly impact the future landscape of the pharmacy industry, making Rite Aid’s fate a matter of keen interest and intense scrutiny.

The Department of Justice’s lawsuit against Rite Aid, alleging its contribution to the opioid crisis, adds another layer of complexity to this already convoluted narrative.

The lawsuit contends that Rite Aid knowingly participated in the proliferation of unlawful prescriptions for drugs, violating both the False Claims Act and the Controlled Substances Act.

Rite Aid, in response, has taken steps to challenge the Justice Department’s lawsuit and has categorically refuted all allegations of illegal prescription practices.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.